ACI’s 5th Annual Life Sciences IP Due Diligence Summit is devoted to providing corporate and IP counsel with expert strategies for assessing, valuing and commercializing IP assets when conducting strategic IP due diligence which is essential to nearly every corporate transaction. Our esteemed speakers will provide insights on what to look for during the due diligence process, when to report findings, how to communicate effectively within and across teams, and when to adjust your expectations and decisions as the process proceeds.

The founding partner Mr. Miao (Daniel) Cheng at Cheng & Peng is invited to give speech as the only speaker from the Asian-Pacific region.